急性心肌梗死合并缺血性二尖瓣反流研究进展  

Research progress of acute myocardial infarction complicated with ischemic mitral regurgitation

作　　者：宋相为 马翔 何瑞利 SONG xiang-wei;MA Xiang;HE Rui-li(Department of Cardiovascular Medicine,Huaihe Hospital of Henan University,Kaifeng 475000,China)

机构地区：[1]河南大学淮河医院心血管内科,475000 [2]河南大学淮河医院心内科,475000

出　　处：《中国现代药物应用》2024年第17期177-180,共4页Chinese Journal of Modern Drug Application

摘　　要：急性心肌梗死(AMI)是一种危及生命的急重症,因发病率高,预后差,严重危害我国居民的身体健康,现我国AMI的发病率整体呈逐年升高的趋势,缺血性二尖瓣反流(IMR)往往在AMI后发生,尽管外科手术和经皮冠状动脉介入治疗(PCI)已发展成熟,但其与不良预后仍紧密相关。尽早行血运重建是AMI的最佳治疗方法,且可以改善IMR及患者预后。本文将探讨AMI合并IMR的病理、诊断与当前的外科及经皮冠状动脉介入治疗方式,以及经皮冠状动脉介入治疗对IMR的影响。Acute myocardial infarction(AMI) is a life-threatening acute and severe disease.Because of its high incidence and poor prognosis,it seriously endangers the health of Chinese residents.At present,the incidence of AMI in China is increasing year by year.Ischemic mitral regurgitation(IMR) often occurs after AMI.Despite the maturity of surgery and percutaneous coronary intervention(PCI),it is closely related to its poor prognosis.Early revascularization is the best treatment for AMI,and can improve IMR and the prognosis of patients.This paper will discuss the pathology,diagnosis and current surgical and percutaneous coronary intervention treatment of AMI with IMR,as well as the impact of percutaneous coronary intervention on IMR.

关 键 词：缺血性二尖瓣反流 急性心肌梗死 超声心动图 二尖瓣置换 经皮冠状动脉介入治疗 

分 类 号：R542.22[医药卫生—心血管疾病] R542.51[医药卫生—内科学]